Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Moderna, Inc.

< Previous 1 2 3 4 5 Next >
Moderna Announces FDA Authorization of Third Dose of COVID-19 Vaccine for Immunocompromised Individuals
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Announces New Study Showing Its COVID-19 Vaccine Maintains Antibodies Against Variants of Concern and Interest to 6 Months
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Australian Therapeutic Goods Administration Grants Provisional Registration for Moderna’s COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Named Fast Company’s 2021 Best Workplace for Innovators
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Receives FDA Fast Track Designation for Respiratory Syncytial Virus (RSV) Vaccine (mRNA-1345)
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Announces First Participant Dosed in Phase 1 Study of Its IL-2 mRNA Therapeutic
From Moderna, Inc.
Via Business Wire
Tickers MRNA
EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of the Moderna COVID-19 Vaccine in Adolescents (12-17 Years of Age) in the European Union
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Announces Establishment of New Charitable Foundation
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Announces New Supply Agreement with Taiwan for 20 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022 and 15 Million Doses in 2023
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Partners with Takeda and the Government of Japan to Supply Additional 50 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna to Report Second Quarter Financial Results on Thursday, August 5, 2021
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Announces Supply Agreement with Argentina for 20 Million Doses of its COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Announces First Participant Dosed in Phase 1/2 Study of Its Quadrivalent Seasonal Flu mRNA Vaccine
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Announces Recipharm Site in France Manufacturing COVID-19 Vaccine Moderna Following Approval by European Medicines Agency
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Announces Emergency Use Authorization for its COVID-19 Vaccine Granted by Government of India
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Provides a Clinical Update on the Neutralizing Activity of its COVID-19 Vaccine on Emerging Variants Including the Delta Variant First Identified in India
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Kate Cronin to Join Moderna as Chief Brand Officer on July 12
From Moderna, Inc.
Via Business Wire
Tickers MRNA
European Commission Purchases Additional 150 Million Doses of Moderna’s COVID-19 Vaccine for Delivery in 2022
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Reaffirms Commitment to Job Creation in Massachusetts
From Moderna, Inc.
Via Business Wire
Tickers MRNA
U.S. Government Purchases Additional 200 Million Doses of Moderna’s COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna and Magenta Partner to Distribute Moderna’s COVID-19 Vaccine and Updated Variant Booster Candidates in United Arab Emirates
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Dr. Paul Burton to Join Moderna as Chief Medical Officer
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Files for Emergency Use Authorization for its COVID-19 Vaccine in Adolescents in the United States
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna and Medison Pharma Partner to Commercialize Moderna’s COVID-19 Vaccine Across Central Eastern Europe and Israel
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Files for Authorization with Health Canada for its COVID-19 Vaccine in Adolescents
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Files for Conditional Marketing Approval for its COVID-19 Vaccine in Adolescents in the European Union
From Moderna, Inc.
Via Business Wire
Tickers MRNA
Moderna Announces Agreement to Supply the Republic of Botswana with its COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Tickers MRNA
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.